Nexus NeuroTech Ventures
San Francisco, California, United StatesFounded 2023
Nexus NeuroTech Ventures was a brain-focused venture capital firm founded in 2023 in San Francisco, investing in technology-based solutions for neurological and psychiatric disorders. The firm concluded operations on March 31, 2026, and its portfolio was absorbed into Sergey Brin's family office, Bayshore Global Management.
33% of their portfolio is in Healthcare. Average disclosed round size is $56.9M (across 11 rounds with reported amounts).
Portfolio
13
Fund Size
$126M
Top Stage
Growth
Last 12 Mo
3
Team
JL
Jon Lundt
Principal
ER
Edward Ruppel III
Investor
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
15 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Lotus Neuro | Unknown | — | Dec 2025 |
 Modulight.Bio | Seed | $12.2M | Nov 2025 |
 Modulight | Seed | — | Nov 2025 |
 Nobi | Series B | — | Jan 2025 |
| MModulight Biotherapeutics | Seed | $12.2M | Jan 2025 |
 Cala Health | Growth | $50M | Dec 2024 |
 Synapticure | Series A | $25M | Nov 2024 |
 INSIGHTEC | Growth | $150M | Jun 2024 |
| EEarliTec Diagnostics | Series B | $21.5M | Apr 2024 |
 Rune Labs | Unknown | $12M | Jan 2024 |
| INSIGHTEC | Growth | $150M | Jan 2024 |
| EEarliTec Diagnostics | Series B | $21.5M | Jan 2024 |
 EarliPoint Health | Series B | $21.5M | — |
| NNeuraWorx | Seed | — | — |
 Insightec | Growth | $150M | — |
Top Co-Investors
Fresh.fund3 shared
Jibe Ventures3 shared
Secret Chord Ventures3 shared
Catalio Capital Management3 shared
Baillie Gifford3 shared
Ally Bridge Group3 shared
Phoenix Court Group2 shared
Blu Ventures2 shared
Fidelity Investments2 shared
Gilmartin Capital2 shared
Perceptive Advisors2 shared
Action Potential Venture Capital1 shared
Vertex Growth Fund1 shared
Ascension Ventures1 shared
SJF Ventures1 shared
GV1 shared
Triventures1 shared
Lightstone Ventures1 shared
Trinity Capital Inc.1 shared
Last updated: 20 October 2026